.svg)
Bronwyn has over 18 years executive experience in the health technology sector spanning commercialisation, venture capital, corporate development, capital raising and industry advocacy.
Formerly an Investment Director with leading healthcare VC, BioScience Managers, Bronwyn has managed over $65M of private and public equity capital raisings and been actively involved in over $30M of portfolio investments.
In 2017, Bronwyn founded ANDHealth, Australia’s only dedicated digital health accelerator & commercialisation support organisation. Now Australia’s leading health technology scale up accelerator, ANDHealth’s unique industry-led model has led to significant growth within Australia’s nascent digital health sector.
Bronwyn holds a number of health, technology and innovation advisory roles both in Australia and internationally. She has a Masters of Commercial Law from the University of Melbourne and a Bachelor of Commerce from the University of Western Australia. Bronwyn is Non-Executive Director and Chair of the Nomination & Remuneration Committee for Lumos Diagnostics.
Advisory roles:
• Australia New Zealand Leadership Forum Health Technologies Sector Group
• NSW Cyber Security Industry Standards Harmonisation Taskforce
• OUTBREAK Project Data Governance Advisory Committee
• RMIT University Health and BioMedical Sector Expert Research Advisory Group
• Swinburne University Innovation Precinct Advisory Board
• La Trobe University Digital Health Advisory Committee
With executive management and board level experience spanning government, commercial and academic sectors, Damien Millen brings strong management, advisory and industry sector knowledge to ANDHealth. Damien has specialised in the areas of innovation, commercialisation, law and investment. With a demonstrable track record in achieving high yield investments for government and commercial parties, Damien is recognised for providing high-quality advice to government and the sector and leading high value projects within government and industry. He has deep experience in developing and implementing complex agreements and projects on a state, national and international level and sourcing funding and development of innovative, early stage technologies. Damien has tertiary qualifications in law, biotechnology, technology management, finance and investment. He was admitted as a Legal Practitioner of the Supreme Court of NSW in 1998.
With degrees in both Chemical Engineering and Immunology from the University of Melbourne, Grace has a track record in project management, clinical validation and commercialisation within the medtech and digital health sectors. She has previously held roles in the Project Management team at CSL Group and has been involved in the creation of multiple medtech businesses in her role as Business Development Manager of Grey Innovation. Grace is a co-inventor on a now ASX listed digital health technology developed with Monash University and has been actively involved in the development of health technologies from invention, through clinical trials, to commercialisation.
Grace has a passion for the nexus of invention, opportunity and business strategy; supporting good ideas reach their audience and survive when backed by strong and sustainable business strategy
Kim is the GM of Investment for ANDHealth, where she leads the flagship ANDHealth+ program supporting digital health companies along the journey from early product through clinical and commercial validation, reimbursement and go-to-market strategy, and scale-up. Kim brings a global track record in digital health commercialisation, innovation strategy, and digital transformation to this role.
She began her career with Braxton/ Deloitte in North America and Europe, before taking operational roles at an e-learning startup and The Body Shop, where she established the company’s first direct-to-consumer analytics and relationship management function. Kim came to healthcare in 2010 to design and deliver a novel, data-driven support program for cardiovascular patients. In 2015 she helped establish a CTO office in Silicon Valley for AstraZeneca, where she led an external innovation team that partnered with emerging technology vendors and startups to deliver more than a dozen proof-of-concept pilots, including the company's first fully virtual clinical trials. She has held local and global roles in strategy and digital innovation in the pharmaceutical industry and as an independent advisor to start-ups on go-to-market and partnering strategy.
Kim is passionate about working with multi-disciplinary teams to bring healthcare innovation to market, and to promote Australian innovation to the world.
Andrew is an experienced corporate affairs executive and senior leader who has worked in peak industry bodies and the not-for-profit sector and has specialised knowledge developing communications that create an enduring social impact.
He has a track record delivering initiatives across a breadth of different topics and audiences including farming, FMCG and social causes. Andrew has led teams to conceptualise innovative advocacy and communications solutions, including several landmark campaigns to enhance children’s wellbeing internationally and improve education about First Nations peoples in Australia.
Andrew brings to ANDHealth extensive experience in government engagement, corporate strategy, crisis management, media relations and business development. As the former Deputy CEO for the peak vegetable farming body, AUSVEG, he led industry development, scientific communications, media relations and advocacy programs representing the interests of Australian farmers for seven years. Most recently, he spent seven years working for Australia’s largest INGO, World Vision Australia, overseeing policy and advocacy programs spanning several countries. Andrew holds tertiary qualifications in Communications and Multimedia Systems and has a First Class Honours Degree of Bachelor of Communications from Monash University.
Hayley is an events and stakeholder engagement professional with over 15-years experience in the life sciences sector. During her time at AusBiotech, Australia’s biotechnology industry organisation, Hayley played an important role in investment attraction work and advocating for increased capital awareness and input into the sector through new and expanded programs.
Passionate in the areas of strategic planning, collaboration and building and maintaining valuable partnerships, Hayley has managed major international and domestic events including flagship conferences, international trade missions and investment showcases.
Hayley graduated from LaTrobe University with a Bachelor of Business, and has also previously worked at the Victorian Automobile Chamber of Commerce.
Hayley is excited to join the dynamic ANDHealth team and looks forward to working on impactful programs for the Victorian Connected Health Innovation & Commercialisation Centre (CHICC) to support digital health companies connect and communicate their capabilities through the health, industry and government ecosystem.
Numa graduated from Monash University with a Bachelor of Science - Global Challenges (Hons) majoring in Genetics. Whilst working at a CRO as a clinical trial coordinator, Numa gained an insight into the world of clinical trials and invaluable experience in project management and stakeholder liaison. Numa has also gained experience working in, and working with start-up companies from her university days, when she founded a company with the goal to eliminate plastic pollution brought about by sanitary pads.
Numa is deeply interested in emerging technologies and the role these technologies can play in bettering the lives of others.
Max is passionate about the intersection of biomedicine, technology and finance. As Lead Analyst, Max works cross-functionally across the business to uncover industry insights used to position ANDHealth as a leader in the digital health ecosystem. Max also supports the evaluation of digital health companies and is a member of the ANDHealth+ team responsible for deploying MRFF funding to SMEs through the non-dilutive investment program ANDHealth+. Prior to ANDHealth, Max worked at CSIRO Futures, CSIRO’s strategic advisory arm, where he was responsible for translating emerging scientific trends into strategic insights for industry and government clients spanning Health & Biosecurity, Future Industries and Energy & Resources. Max holds a Bachelor of Biomedicine (Biotechnology major) from University of Melbourne.
Kate has a Bachelor of Science (Nutrition) from the University of Wollongong, as well as a PRINCE2 qualification in project management. Kate has proven abilities to coordinate and support large-scale digital health projects, with strong operational and project management experience within the healthcare sector, both in Australia and the UK. Prior to joining ANDHealth, Kate worked as a Senior Project Support Officer for DigitalHealth.London in the UK, an accelerator program aimed at connecting and supporting NHS staff, digital health companies and academics to improve healthcare through digital technology. Kate has also worked as a Nutrition Assistant at St Vincent's Hospital, Sydney. Kate is extremely passionate about improving healthcare delivery and accessibility, and believes that digital health and innovation are essential in achieving this outcome.
With a degree in Health Sciences majoring in Health Promotion and Nutrition, Tayla has experience working in digital health, the start-up ecosystem and across Public Health both in Australia and the UK. Tayla has a strong passion for program management and Community and Industry engagement.
Tayla is the Program Director - LaunchVic at ANDHealth. Tayla has been at ANDHealth for the last two years working closely with the VP Program Design to achieve ANDHealth's program activities, events and communications.
Tayla is profoundly passionate about helping others which is shown in her commitment to voluntary roles and wants to create a career that has a strong positive impact on others.
Bianca holds a Bachelor of Design (Visual Communication) and a Graduate Certificate in Marketing. She has previously worked in the publishing and toy industries, where her favourite projects were educational products for children with a focus on making learning fun. Bianca loves finding creative ways to solve problems visually and teaching herself new skills.
.svg)
Over his 35 year career Gavin has been a leader and champion of Medical Technology in Australia/NZ and Asia. He has also played lead roles in Industry Bodies, Innovation Initiatives and Not for Profit Boards. Gavin is strong advocate for Gender Equality and Indigenous Engagement.
Gavin is currently CEO of Omnigon, a private Australian company in the Ostomy Care market. He is Chair of ANDHealth (Australia’s National Digital Health Initiative), Board Director for Bowel Cancer Australia and Board Director for SAN Foundation. Gavin is a proud member of the Champions of Change Coalition Health group, sits on SBE Life Sciences Council and ARCS Signature Program Advisory Board, and serves as an Ambassador for Rotary Oceania Medical Aid for Children (ROMAC).
Previously, Gavin was Managing Director Australia/NZ and Vice President Asia Pacific for Johnson & Johnson Medical Devices, Chair of the Medical Technology Association of Australia, Governor of American Chamber of Commerce, Co-Founder/Chair of Macquarie Park Business Coalition (in partnership with United Way) and Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum.
Gavin is a Graduate of the Australian Institute of Company Directors.
Bronwyn has over 20 years executive experience in health technology commercialisation, venture capital, capital raising and industry advocacy. In 2017 she founded ANDHealth, an organisation that supports digital health companies in Australia by providing education, resources, non-dilutive funding and mentorship to help them navigate the complexities of the healthcare industry.
ANDHealth is now one of Australia’s leading health technology commercialisation organisations with companies participating in its flagship ANDHealth+ program raising $19.70 in new capital and generating $6.70 in new revenues for every dollar invested. ANDHealth manages over $30M in public and private commitments to digital health commercialisation, and provides specialist support to a further $100M of funding managed by Brandon Capital.
She is a Member of the National Health & Medical Research Council and a Non-Executive Director of Lumos Diagnostics Ltd (ASX.LDX) alongside a number of other advisory roles.
Charlie is an investor, adviser, and entrepreneur in the areas of innovation, science, research and commercialisation. He has over 20 years’ experience working in commercial, academic, and policy settings, and has been invited to speak at conferences in this field in the US, Europe and Asia. Until early 2020, Charlie was the inaugural permanent CEO of the Office of Innovation and Science Australia (now the Office of Industry, Innovation and Science Australia), a role which supported the ISABoard in delivering its mandate to provide strategic advice, program oversight and public advocacy for Australia’s Science and Innovation system. Charlie has a longstanding interest in the creation of new technology-based ventures, having previously been a member of the Investment Committee of the Venture Capital fund Uniseed, and more recently a co-founder of the Melbourne Accelerator Program. He serves on the investment committee for the commercialisation fund of the Murdoch Childrens’ Research Institute and is a mentor and investor at Moonshot Space Accelerator.
Kate Quirke has more than 25 years’ experience in the healthcare information sector. Her background includes senior management roles with several global healthcare software firms. Kate’s experience includes product management, operations delivery and business development, including having developed international markets for Australian developed software.
As Group Managing Director of Alcidion, Kate leads the various elements of the business with a particular focus on sales and marketing and developing business relationships with customers and partners across the world. She is also one of a small number of female CEOs of an ASX listed health technology company, giving her a unique view into the later stage capital markets facing ANDHealth’s program participants.
With executive management and board level experience spanning government, commercial and academic sectors, Damien Millen brings strong management, advisory and industry sector knowledge to ANDHealth. Damien has specialised in the areas of innovation, commercialisation, law and investment. With a demonstrable track record in achieving high yield investments for government and commercial parties, Damien is recognised for providing high-quality advice to government and the sector and leading high value projects within government and industry. He has deep experience in developing and implementing complex agreements and projects on a state, national and international level and sourcing funding and development of innovative, early stage technologies. Damien has tertiary qualifications in law, biotechnology, technology management, finance and investment. He was admitted as a Legal Practitioner of the Supreme Court of NSW in 1998.
